Chengyao Feng

Hunan Key Laboratory Of Tumor Models And Individualized Medicine
Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Dual Targeting of m7G tRNA Modification and Histone Acetylation using Carrier-Free Nano-Epidrugs to Evoke Osteosarcoma Chemosensitization.

Dual Targeting of m7G tRNA Modification and Histone Acetylation using Carrier-Free Nano-Epidrugs to Evoke Osteosarcoma Chemosensitization.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 28, 2025

Identification and validation of SAC3D1 as a prognostic biomarker promoting the development of osteosarcoma.

Identification and validation of SAC3D1 as a prognostic biomarker promoting the development of osteosarcoma.

Journal: Scientific reports
Published: March 17, 2025

Leveraging multiple cell-death patterns based on machine learning to decipher the prognosis, immune, and immune therapeutic response of soft tissue sarcoma.

Leveraging multiple cell-death patterns based on machine learning to decipher the prognosis, immune, and immune therapeutic response of soft tissue sarcoma.

Journal: Discover oncology
Published: January 04, 2025

PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma.

PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma.

Journal: Signal transduction and targeted therapy
Published: October 31, 2024

Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma.

Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma.

Journal: International immunopharmacology
Published: October 03, 2024

Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma.

Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma.

Journal: Oncogene
Published: June 09, 2024

PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT.

PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT.

Journal: Cancer research
Published: January 17, 2024

Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning.

Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning.

Journal: Frontiers in immunology
Published: October 14, 2023

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma.

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma.

Journal: MedComm
Published: March 09, 2023

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.

Journal: Frontiers in immunology
Published: March 02, 2023

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma.

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma.

Journal: Frontiers in genetics
Published: February 08, 2023

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.

Journal: Frontiers in immunology
Published: October 16, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026